OHMX.bio is an innovative Contract Research Organisation (CRO) within the Anacura Group, dedicated to accelerating preclinical and clinical research through advanced OMICS technologies. We provide end-to-end support, from study design to data analysis, helping researchers achieve faster and more reliable results. Our expertise spans genomics, long-read sequencing, proteomics, ribosome profiling, qPCR and bioinformatics, enabling comprehensive solutions for a wide range of research applications. By combining scientific expertise with cutting-edge technology, OHMX.bio delivers high-quality, customised OMICS services that empower pharmaceutical companies, biotechnology firms and academic researchers to advance discovery, improve decision-making and drive innovation in life sciences.